Hashim Ali is a Research Associate at the Division of Virology, University of Cambridge, Cambridge, UK. He completed his PhD in HIV-1 integration biology in 2015 at the International Centre for Genetic Engineering and Biotechnology (ICGEB) in Trieste, Italy. He has published 15 peer-reviewed research articles and has led several research projects to completion. In 2019, he joined King's College London, UK, where he worked on the SARS-CoV2 spike protein and identified several anti-fusogenic inhibitors and proposed the potential mechanism of spike-induced syncytia formation. His research interest is to study the host–pathogen interactions, particularly the role of host posttranslational modifications in the +ssRNA virus (SARS-CoV2, enteric viruses, and flaviviruses) replication and innate immune responses.